戻る
「早戻しボタン」を押すと検索画面に戻ります。

今後説明を表示しない

[OK]

コーパス検索結果 (1語後でソート)

通し番号をクリックするとPubMedの該当ページを表示します
1                              Warfarin should be continued for 1 month after cardioversion to allow fo
2                                  Therapy has been continued for 1 year in responders.
3                     In 15 patients, the drug was continued for 1 to 14 days while other possible caus
4 r 12 weeks with trastuzumab, and trastuzumab was continued for 1 year.
5                    Treatment with study drug was continued for 10 days, until the peak white blood ce
6 cin after becoming bacteremic, and treatment was continued for 10 days.
7           Chest compressions and ventilation were continued for 10 mins.
8 in lesion area gradually subsided as the WTD was continued for 12 and 16 weeks.
9  one of the four irbesartan doses, treatment was continued for 12 weeks and hemodynamic measurements
10  was seen in those patients in whom anakinra was continued for 12 weeks.
11  by gavage starting at 16 weeks after VC and was continued for 12 weeks.
12 09, 3 mg/kg/d) was given 1 week after MI and was continued for 12 weeks.
13                            This chemotherapy was continued for 13 total courses for some patients, wh
14 itiated 11 days after MAb administration and was continued for 13 weeks in all treated animals.
15                                       Pacing was continued for 14 days, and final studies were obtain
16 oped but was reduced when allergen challenge was continued for 15 days.
17                               Drug treatment was continued for 15 weeks.
18                                      Therapy was continued for 176 +/- 117 days, and follow-up includ
19                       Maintenance injections were continued for 18 months or longer.
20                       Normothermic perfusion was continued for 2 hr before in situ cold perfusion wit
21 ot successful, cardiopulmonary resuscitation was continued for 2 mins before the next defibrillation.
22 the drinking water, and the cholesterol diet was continued for 2 weeks, at which time the aortas were
23                                   Study drug was continued for 24 to 72 hours, and Holter monitoring
24 le after exposure (within 72 hours) and must be continued for 28 days.
25 gents was started about 1 week after MNU and was continued for 29 weeks with DFMO.
26         In the remaining 9 dogs, reperfusion was continued for 3 hours, when MCE was repeated before
27 ed after 1 week as penile rehabilitation and was continued for 3 months.
28 tinued, but the diet with Gln or Gln placebo was continued for 3 months.
29                                    Treatment was continued for 3 months.
30 ed to active drug, and prospective follow-up was continued for 3 years.
31  with oral methotrexate and 6-mercaptopurine was continued for 30 months.
32                Cardiopulmonary resuscitation was continued for 307 minutes after rescue until venoart
33                     The inhaled prostacyclin was continued for 4 days postoperatively, with no signs
34 quid ventilation or conventional ventilation was continued for 4 hrs before the animals were killed.
35        The combination antimicrobial therapy was continued for 42 days and the infection was successf
36                      Selective brain cooling was continued for 45 mins of reperfusion after which pas
37                                     The scan was continued for 45 minutes after levodopa intake or un
38 centrations or Ringer solution and perfusion was continued for 45-60 min.
39  activity; the St John's wort dosing regimen was continued for 48 hours.
40                                    Treatment was continued for 48 weeks if patients had undetectable
41  was started within 24 hrs of enrollment and was continued for 5 days or until the white blood cell c
42 iven 24 hours after infection, and treatment was continued for 5 days.
43  began showing signs of growth and treatment was continued for 5 weeks.
44                                  Ventilation was continued for 5.5 hrs.
45                                 All regimens were continued for 5 days.
46 hemotherapy or biological therapy and should be continued for 6-12 months after discontinuation of su
47 ects at higher dosages; (3) treatment should be continued for 6-12 months to potentially prevent rela
48                     Interferon-alpha therapy was continued for 6 to 9 months in the eight patients ju
49                              Both conditions were continued for 6 weeks.
50 , when exposure of the differentiating cells was continued for 6days, AC activities then became supra
51 copic plugged catheter, antibiotic treatment was continued for 7 days.
52        Diets and linseed oil supplementation were continued for 7 to 12 weeks.
53 red for 2 wk before inoculation of tumor and was continued for 8 wk, resulting in significant inhibit
54                             Treatment was to be continued for a minimum of 6 months and a maximum of
55 loxifene will gain BMD if the same treatment is continued for a second year.
56  administered for 1 week prior to lesion and was continued for a further 2 weeks.
57 eye combinations were reversed and lens wear was continued for a further 6 months, followed by anothe
58              However, when ethanol treatment was continued for a longer time, there was a significant
59                                    Treatment was continued for a maximum of 16 weeks.
60                                  Maintenance was continued for a maximum of four rituximab courses or
61                                      Therapy was continued for a maximum of six cycles.
62  of 2 weeks; step-down therapy with an azole was continued for a median duration of 12 months.
63                                      Therapy was continued for a minimum of 48 hours to a maximum of
64 23 BLTx for severe PH, ECMO used during BLTx was continued for a minimum of 5 days (BLTx-ECMO group).
65                                    Treatment was continued for a total of 230 mins.
66                            Endocrine therapy was continued for a total of 5 years, and breast irradia
67                          Study interventions were continued for a median (IQR) of 41 (30-57) days and
68 n, or high-frequency oscillatory ventilation was continued for an additional 4 hrs before the animals
69 e of the latter experiment), the superfusion was continued for another 115 min.
70 oved, and iloprost or normal saline infusion was continued for another 60 mins.
71 he abdomen was manually deflated; monitoring was continued for another 60 minutes.
72          After device implantation, warfarin was continued for approximately 45 days, followed by clo
73                                    Treatment was continued for as long as the patients derived clinic
74                              The simulations are continued for at least 1s of leukocyte rolling durin
75 tibiotics ordered in critically ill patients are continued for at least 72 hours in absence of adjudi
76 eatment of GAD with an antidepressant should be continued for at least 12 months.
77 of disease progression, and treatment should be continued for at least 12 weeks to ensure adequate dr
78                                    Treatment was continued for at least 24 months in patients who sho
79 Of the empiric antibiotics, 333 of 660 (50%) were continued for at least 72 hours in instances where
80 ated if suppressive antiretroviral treatment is continued for extremely long periods of time.
81 er completion of local therapy, chemotherapy was continued for four to 15 cycles, followed by radioth
82                                  Medications were continued for four weeks, at which time, the final
83                    However, treatment has to be continued for life because it does not lead to the fu
84  larger decrements in life expectancy if HRT was continued for life (-0.79 to -1.09 years).
85 ide reverse transcriptase inhibitors (NRTIs) were continued for median nine days after NNRTI interrup
86 cally treated patients, antibiotic treatment was continued for more than 24 hours because of acute co
87 ension, the question of how long they should be continued for prevention of variceal hemorrhage remai
88 b was administered at the end of cycle 1 and was continued for seven cycles.
89                             The drug therapy was continued for six months post-operatively.
90 eatment began on the same day as surgery and was continued for the 16-day duration of study.
91 e infusion with iloprost or carrier solution was continued for the duration of the experiment.
92 as prevented when weekly doses of tacrolimus were continued for the duration of the experiment rather
93 After 8 weeks, dexamethasone mouthwash could be continued for up to eight additional weeks at the dis
94 cebo began during week 4 of radiotherapy and was continued for up to 12 cycles of maintenance chemoth
95  treated for at least 3 months and treatment was continued for up to 12 months.
96  was interrupted, and Peg-interferon alfa-2a was continued for up to 12 weeks (the primary end point)
97 60 mg/m(2) once every 4 weeks, and treatment was continued for up to 12 weeks if no disease progressi
98                                    Treatment was continued for up to 42 months until recovery was ach
99                               The study drug was continued for up to 60 days.

WebLSDに未収録の専門用語(用法)は "新規対訳" から投稿できます。